Jump to main content
Jump to site search


Rational design and action mechanisms of chemically innovative organoselenium in cancer therapy

Author affiliations

Abstract

Organo-seleno compounds (org-Se) have been widely used in antitumor, antiviral, and antiinflammatory therapy; antioxidation and other biological fields. As such, they have made an important contribution to overcoming various kinds of diseases, and researchers are increasingly attracted to org-Se's synthesis and functional design. This review is mainly focused on the design and synthesis of various kinds of org-Se, followed by their anticancer mechanisms such as the mitochondria mediated pathway induced by ROS, death receptor mediated pathways involving p53 phosphorylation, and the activation of the AMPK pathway to promote apoptosis. Org-Se also serves as a sensitizer in chemotherapy and radiotherapy, and an antagonist against the cytotoxic effects induced by chemotherapeutic agents. Finally, we will summarize the development of cancer-targeted org-Se containing complexes, and nanotechnology-based org-Se for anticancer application. This review could provide information for the future design of chemically innovative org-Se with anticancer potential, and shed light on the discovery of nanomaterial-based pharmaceuticals to improve drug development and formation.

Graphical abstract: Rational design and action mechanisms of chemically innovative organoselenium in cancer therapy

Back to tab navigation

Publication details

The article was received on 30 Sep 2019, accepted on 11 Nov 2019 and first published on 12 Nov 2019


Article type: Feature Article
DOI: 10.1039/C9CC07683B
Chem. Commun., 2020, Advance Article

  •   Request permissions

    Rational design and action mechanisms of chemically innovative organoselenium in cancer therapy

    Z. Chen, H. Lai, L. Hou and T. Chen, Chem. Commun., 2020, Advance Article , DOI: 10.1039/C9CC07683B

Search articles by author

Spotlight

Advertisements